Target’s price cuts are a sign of strength, some analysts say. Investors disagree.
MarketWatch· Bill Peters· Sep 29, 2026 · 9:33 PM
A Jefferies analyst sees Target “prioritizing the health of the franchise over short-term profit optimization.”
This is a summary. Read the complete story at MarketWatch below.
Read full article at MarketWatchRelated Stories
marketsabout 3 hours ago
Hollywood’s big debt deal hits a wall of higher yields as Paramount finances Warner Bros. buyout
The Paramount financing will be a closely watched barometer of dealmaking appetite despite rising borrowing costs in 2026.
MarketWatch
marketsabout 3 hours ago
Could SpaceX be worth $12 trillion one day? Citi says Starship gets it a step closer.
The recent Starship launch helps SpaceX with a number of priorities that could help its stock reach $900 over the long run, an analyst says.
MarketWatch
marketsabout 3 hours ago
The real prize in AMD’s $8 billion World Labs acquisition isn’t what you’d think
AMD is getting cutting-edge spatial-intelligence models, but more importantly, a leader who can help recruit top talent and bring real-world AI applications into focus.
MarketWatch